Royal Bank of Canada’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-4,089
| Closed | -$4K | – | 7382 |
|
|
2019
Q4 | $4K | Buy |
4,089
+390
| +11% | +$299 | ﹤0.01% | 6456 |
|
|
2019
Q3 | $2K | Sell |
3,699
-75
| -2% | -$40 | ﹤0.01% | 6373 |
|
|
2019
Q2 | $2K | Sell |
3,774
-628
| -14% | -$314 | ﹤0.01% | 6662 |
|
|
2019
Q1 | $1K | Buy |
4,402
+629
| +17% | +$294 | ﹤0.01% | 6753 |
|
|
2018
Q4 | $1K | Sell |
3,773
-261
| -6% | -$130 | ﹤0.01% | 6686 |
|
|
2018
Q3 | $2K | Sell |
4,034
-1,206
| -23% | -$647 | ﹤0.01% | 6574 |
|
|
2018
Q2 | $2K | Buy |
5,240
+506
| +11% | +$236 | ﹤0.01% | 6321 |
|
|
2018
Q1 | $1K | Sell |
4,734
-10
| -0.2% | -$4 | ﹤0.01% | 6281 |
|
|
2017
Q4 | $1K | Buy |
4,744
+378
| +9% | +$143 | ﹤0.01% | 6487 |
|
|
2017
Q3 | $1K | Sell |
4,366
-208
| -5% | -$77 | ﹤0.01% | 6663 |
|
|
2017
Q2 | $1K | Buy |
4,574
+1,000
| +28% | +$408 | ﹤0.01% | 6528 |
|
|
2017
Q1 | $1K | Buy |
3,574
+438
| +14% | +$192 | ﹤0.01% | 6562 |
|
|
2016
Q4 | $1K | Buy |
3,136
+309
| +11% | +$105 | ﹤0.01% | 6603 |
|
|
2016
Q3 | $1K | Sell |
2,827
-933
| -25% | -$236 | ﹤0.01% | 6363 |
|
|
2016
Q2 | $1K | Buy |
3,760
+337
| +10% | +$58 | ﹤0.01% | 6331 |
|
|
2016
Q1 | $0 | Buy |
3,423
+164
| +5% | +$18 | ﹤0.01% | 7160 |
|
|
2015
Q4 | $0 | Buy |
3,259
+1,345
| +70% | +$190 | ﹤0.01% | 7299 |
|
|
2015
Q3 | $0 | Buy |
1,914
+274
| +17% | +$93 | ﹤0.01% | 7113 |
|
|
2015
Q2 | $1K | Sell |
1,640
-249
| -13% | -$172 | ﹤0.01% | 6553 |
|
|
2015
Q1 | $1K | Hold |
1,889
| – | – | ﹤0.01% | 6086 |
|
|
2014
Q4 | $1K | Hold |
1,889
| – | – | ﹤0.01% | 6132 |
|
|
2014
Q3 | $1K | Hold |
1,889
| – | – | ﹤0.01% | 5938 |
|
|
2014
Q2 | $1K | Hold |
1,889
| – | – | ﹤0.01% | 5891 |
|
|
2014
Q1 | $1K | Sell |
1,889
-31
| -2% | -$12 | ﹤0.01% | 5861 |
|
|
2013
Q4 | $1K | Sell |
1,920
-601
| -24% | -$726 | ﹤0.01% | 5889 |
|
|
2013
Q3 | $5K | Buy |
2,521
+14
| +0.6% | +$27 | ﹤0.01% | 5664 |
|
|
2013
Q2 | $5K | Buy |
+2,507
| New | +$4.4K | ﹤0.01% | 5476 |
|
Royal Bank of Canada's GCVRZ Position: Q1 2020 in Review
Royal Bank of Canada sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 4,089 shares — an estimated $4K sold.
Royal Bank of Canada first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $5K in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Royal Bank of Canada reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Royal Bank of Canada sold 4,089 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $4K.
- Royal Bank of Canada first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
- Royal Bank of Canada's Sanofi Contingent Value Rights position peaked at $5K in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Royal Bank of Canada's 13F filing for Q1 2020, filed 15 May 2020.